CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients

Hyperinflammation distinguishes COVID-19 patients who develop a slight disease or none, from those progressing to severe and critical conditions. CIGB-258 is a therapeutic option for the latter group of patients. This drug is an altered peptide ligand (APL) derived from the cellular stress protein 6...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Stress Chaperones
Main Authors: Hernandez-Cedeño, M., Venegas-Rodriguez, R., Peña-Ruiz, R., Bequet-Romero, M., Santana-Sanchez, R., Penton-Arias, E., Martinez-Donato, G., Guillén-Nieto, G., Dominguez-Horta, María del Carmen
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Netherlands 2021
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7904296/
https://ncbi.nlm.nih.gov/pubmed/33629254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12192-021-01197-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados